BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 24567196)

  • 21. Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis.
    Urquidi V; Sloan D; Kawai K; Agarwal D; Woodman AC; Tarin D; Goodison S
    Clin Cancer Res; 2002 Jan; 8(1):61-74. PubMed ID: 11801541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential characteristics of heart, liver, and brain metastatic subsets of murine breast carcinoma.
    Erin N; Kale S; Tanrıöver G; Köksoy S; Duymuş O; Korcum AF
    Breast Cancer Res Treat; 2013 Jun; 139(3):677-89. PubMed ID: 23760857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apoptosis-, proliferation, immune function-, and drug resistance- related genes in ER positive, HER2 positive and triple negative breast cancer.
    Kolacinska A; Chalubinska J; Zawlik I; Szymanska B; Borowska-Garganisz E; Nowik M; Fendler W; Kubiak R; Pawlowska Z; Morawiec Z; Szemraj J
    Neoplasma; 2012; 59(4):424-32. PubMed ID: 22489698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
    Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cyan fluorescent protein nude mouse as a host for multicolor-coded imaging models of primary and metastatic tumor microenvironments.
    Suetsugu A; Hassanein MK; Reynoso J; Osawa Y; Nagaki M; Moriwaki H; Saji S; Bouvet M; Hoffman RM
    Anticancer Res; 2012 Jan; 32(1):31-8. PubMed ID: 22213285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of clinically relevant in vivo metastasis models using human bone discs and breast cancer patient-derived xenografts.
    Lefley D; Howard F; Arshad F; Bradbury S; Brown H; Tulotta C; Eyre R; Alférez D; Wilkinson JM; Holen I; Clarke RB; Ottewell P
    Breast Cancer Res; 2019 Nov; 21(1):130. PubMed ID: 31783893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A functional in vitro model of heterotypic interactions reveals a role for interferon-positive carcinoma associated fibroblasts in breast cancer.
    Hosein AN; Livingstone J; Buchanan M; Reid JF; Hallett M; Basik M
    BMC Cancer; 2015 Mar; 15():130. PubMed ID: 25884794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular characterization of breast cancer cell lines through multiple omic approaches.
    Smith SE; Mellor P; Ward AK; Kendall S; McDonald M; Vizeacoumar FS; Vizeacoumar FJ; Napper S; Anderson DH
    Breast Cancer Res; 2017 Jun; 19(1):65. PubMed ID: 28583138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metastatic breast cancer cells in lymph nodes increase nodal collagen density.
    Rizwan A; Bulte C; Kalaichelvan A; Cheng M; Krishnamachary B; Bhujwalla ZM; Jiang L; Glunde K
    Sci Rep; 2015 May; 5():10002. PubMed ID: 25950608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell type of origin as well as genetic alterations contribute to breast cancer phenotypes.
    Bhagirath D; Zhao X; West WW; Qiu F; Band H; Band V
    Oncotarget; 2015 Apr; 6(11):9018-30. PubMed ID: 25940703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative analysis of gene regulatory networks of highly metastatic breast cancer cells established by orthotopic transplantation and intra-circulation injection.
    Nakayama J; Ito E; Fujimoto J; Watanabe S; Semba K
    Int J Oncol; 2017 Feb; 50(2):497-504. PubMed ID: 28000849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer-associated fibroblasts stimulate primary tumor growth and metastatic spread in an orthotopic prostate cancer xenograft model.
    Linxweiler J; Hajili T; Körbel C; Berchem C; Zeuschner P; Müller A; Stöckle M; Menger MD; Junker K; Saar M
    Sci Rep; 2020 Jul; 10(1):12575. PubMed ID: 32724081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of Patient Derived Xenograft Models of Overt Spontaneous Breast Cancer Metastasis: A Cautionary Note.
    Paez-Ribes M; Man S; Xu P; Kerbel RS
    PLoS One; 2016; 11(6):e0158034. PubMed ID: 27355476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer.
    Englund E; Bartoschek M; Reitsma B; Jacobsson L; Escudero-Esparza A; Orimo A; Leandersson K; Hagerling C; Aspberg A; Storm P; Okroj M; Mulder H; Jirström K; Pietras K; Blom AM
    Oncogene; 2016 Oct; 35(43):5585-5596. PubMed ID: 27065333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of murine xenograft models of brain tumors from primary human tissue for in vivo analysis of the brain tumor-initiating cell.
    Qazi M; Mann A; van Ommeren R; Venugopal C; McFarlane N; Vora P; Singh SK
    Methods Mol Biol; 2014; 1210():37-49. PubMed ID: 25173159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comprehensive characterization of cell cultures and xenografts derived from a human verrucous penile carcinoma.
    Muñoz JJ; Drigo SA; Kuasne H; Villacis RA; Marchi FA; Domingues MA; Lopes A; Santos TG; Rogatto SR
    Tumour Biol; 2016 Aug; 37(8):11375-84. PubMed ID: 26960831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suicide Gene-Engineered Stromal Cells Reveal a Dynamic Regulation of Cancer Metastasis.
    Shen K; Luk S; Elman J; Murray R; Mukundan S; Parekkadan B
    Sci Rep; 2016 Feb; 6():21239. PubMed ID: 26893143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IMP1, an mRNA binding protein that reduces the metastatic potential of breast cancer in a mouse model.
    Nwokafor CU; Sellers RS; Singer RH
    Oncotarget; 2016 Nov; 7(45):72662-72671. PubMed ID: 27655671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of neuroimmune pathways increases therapeutic effects of radiotherapy on poorly differentiated breast carcinoma.
    Erin N; Korcum AF; Tanrıöver G; Kale Ş; Demir N; Köksoy S
    Brain Behav Immun; 2015 Aug; 48():174-85. PubMed ID: 25736062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease.
    Garcia-Recio S; Thennavan A; East MP; Parker JS; Cejalvo JM; Garay JP; Hollern DP; He X; Mott KR; Galván P; Fan C; Selitsky SR; Coffey AR; Marron D; Brasó-Maristany F; Burgués O; Albanell J; Rojo F; Lluch A; de Dueñas EM; Rosen JM; Johnson GL; Carey LA; Prat A; Perou CM
    J Clin Invest; 2020 Sep; 130(9):4871-4887. PubMed ID: 32573490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.